@article{cacdbe583e36419596e8afadfdea3881,
title = "Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis",
keywords = "AML, Acute myeloid leukemia, Enasidenib, Gilteritinib, HMA, Hypomethylating agents, Ivosidenib, Outcomes, Targeted therapies, Venetoclax",
author = "Vishesh Khanna and Tali Azenkot and Liu, {Selina (Qiuying)} and Jason Gilbert and Edna Cheung and Kimberly Lau and Pollyea, {Daniel A.} and Elie Traer and Jonas, {Brian A.} and Zhang, {Tian Y.} and Mannis, {Gabriel N.}",
note = "Funding Information: VK would like to acknowledge support from the Stanford Department of Medicine{\textquoteright}s Translational Investigator Program. ",
year = "2023",
month = aug,
doi = "10.1016/j.leukres.2023.107331",
language = "English (US)",
volume = "131",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
}